NTIC
CRL icon

Napean Trading & Investment Company’s Charles River Laboratories CRL Stock Holding History

Napean Trading & Investment Company’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-18,332
Closed -$3.61M – 36
2024
Q3 		$3.61M Buy
18,332
+8,057
+78% +$1.67M 0.88% 35
2024
Q2 		$2.12M Hold
10,275
– – 0.5% 42
2024
Q1 		$2.78M Buy
+10,275
New +$2.45M 0.68% 39

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

Napean Trading & Investment Company's CRL Position: Q4 2024 in Review

Napean Trading & Investment Company sold out of Charles River Laboratories (CRL) in Q4 2024, closing a stake of 18,332 shares — an estimated $3.61M sold.

Napean Trading & Investment Company first reported a position in CRL in Q1 2024 and held it in 3 quarters. The position peaked at $3.61M in Q3 2024. 636 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

  • Napean Trading & Investment Company reported no remaining Charles River Laboratories position as of Q4 2024 after selling out during the quarter.
  • Napean Trading & Investment Company sold 18,332 Charles River Laboratories shares in Q4 2024, an estimated $3.61M.
  • Napean Trading & Investment Company first reported a position in Charles River Laboratories in Q1 2024 and held it in 3 quarters.
  • Napean Trading & Investment Company's Charles River Laboratories position peaked at $3.61M in Q3 2024.
  • 636 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on Napean Trading & Investment Company's 13F filing for Q4 2024, filed 11 Feb 2025.